The Effect of Isolated and Synthetic Dietary Fibers on Markers of Metabolic Diseases in Human Intervention Studies: A Systematic Review
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Observational studies provide strong evidence for the health benefits of dietary fiber (DF) intake; however, human intervention studies that supplement isolated and synthetic DFs have shown inconsistent results. Therefore, we conducted a systematic review to summarize the effects of DF supplementation on immunometabolic disease markers in intervention studies in healthy adults, and considered the role of DF dose, DF physicochemical properties, intervention duration, and the placebo used. Five databases were searched for studies published from 1990 to 2018 that assessed the effect of DF on immunometabolic markers. Eligible studies were those that supplemented isolated or synthetic DFs for ≥2 wk and reported baseline data to assess the effect of the placebo. In total, 77 publications were included. DF supplementation reduced total cholesterol (TC), LDL cholesterol, HOMA-IR, and insulin AUC in 36-49% of interventions. In contrast, <20% of the interventions reduced C-reactive protein (CRP), IL-6, glucose, glucose AUC, insulin, HDL cholesterol, and triglycerides. A higher proportion of interventions showed an effect if they used higher DF doses for CRP, TC, and LDL cholesterol (40-63%), viscous and mixed plant cell wall DFs for TC and LDL cholesterol (>50%), and longer intervention durations for CRP and glucose (50%). Half of the placebo-controlled studies used digestible carbohydrates as the placebo, which confounded findings for IL-6, glucose AUC, and insulin AUC. In conclusion, interventions with isolated and synthetic DFs resulted mainly in improved cholesterol concentrations and an attenuation of insulin resistance, whereas markers of dysglycemia and inflammation were largely unaffected. Although more research is needed to make reliable recommendations, a more targeted supplementation of DF with specific physicochemical properties at higher doses and for longer durations shows promise in enhancing several of its health effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
The impact of dietary fiber on gut microbiota in host health and disease
Makki, K., Deehan, E. C., Walter, J., & Bäckhed, F. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.012 · Cited by 2,517 · cited 2×
“Further, fermentation of DF by the gut microbiota leads to the production of SCFAs, which have a wide variety of immunological, metabolic, and hormonal effects, such as promoting satiety, reducing inflammation, and improving glucose and lipid metabolism (19, 20).”
BackgroundSelf-citationArtificial sweeteners induce glucose intolerance by altering the gut microbiota
Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature · doi:10.1038/nature13793 · Cited by 2,067 · cited 1×
“Although artificial sweeteners have been shown to influence glucose metabolism indirectly by acting on the gut microbiota (35), their effects on the reviewed immunometabolic markers are controversial (36).”
BackgroundLudwig (2002) · doi:10.1001/jama.287.18.2414 · Cited by 1,775 · cited 2×
“Our analysis also revealed that more than half of the placebo-controlled trials used digestible carbohydrates as a placebo, which have well-documented detrimental effects on immunometabolic markers (29, 30).”
BackgroundCarbohydrate quality and human health: a series of systematic reviews and meta-analyses
Reynolds, A., Mann, J., Cummings, J., Winter, N., Mete, E., & Te Morenga, L. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31809-9 · Cited by 1,630 · cited 6×
“DF supplements or foods enriched with DF have been proposed as alternatives to whole foods (22, 23), but the health benefits of these diet items have been questioned (5).”
BackgroundInfluentialGlycemic index: overview of implications in health and disease,,,
Jenkins, D. J., Kendall, C. W., Augustin, L. S., Franceschi, S., Hamidi, M., Marchie, A., Jenkins, A. L., & Axelsen, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.266s · Cited by 827
Dietary Fiber and Risk of Coronary Heart Disease: A Pooled Analysis of Cohort Studies
Pereira, M. A., O'Reilly, E., Augustsson, K., Fraser, G. E., Goldbourt, U., Heitmann, B. L., Hallmans, G., Knekt, P., Liu, S., Pietinen, P., et al. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.4.370 · Cited by 630
Kaczmarczyk, M. M., Miller, M. J., & Freund, G. G. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.017 · Cited by 554 · cited 2×
“established mechanisms by which pathologies are prevented (15, 16).”
BackgroundDietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses
Veronese, N., Solmi, M., Caruso, M. G., Giannelli, G., Osella, A. R., Evangelou, E., Maggi, S., Fontana, L., Stubbs, B., & Tzoulaki, I. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx082 · Cited by 536
Mechanisms Underlying the Cholesterol-Lowering Properties of Soluble Dietary Fibre Polysaccharides
Gunness, P., & Gidley, M. J. (2010) · Food & Function · doi:10.1039/c0fo00080a · Cited by 527
Robertson, M. D., Bickerton, A. S., Dennis, A. L., Vidal, H., & Frayn, K. N. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.559 · Cited by 501
Position of the Academy of Nutrition and Dietetics: Health implications of dietary fiber
Dahl, W. J., & Stewart, M. L. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.09.003 · Cited by 471 · cited 1×
“DF is considered by most health professionals and regulatory agencies to be an integral component of a healthy diet, being implicated in the reduction of chronic diseases (3, 4).”
BackgroundCODEX-aligned dietary fiber definitions help to bridge the ‘fiber gap’
Jones, J. M. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-34 · Cited by 422 · cited 4×
“However, society-wide consumption of DF-rich whole foods remains insufficient despite substantial efforts by educators and authorities, resulting in a "fiber gap" (2, 22, 167).”
BackgroundInfluentialGlycemic index: overview of implications in health and disease,,,
Jenkins, D. J., Kendall, C. W., Augustin, L. S., Franceschi, S., Hamidi, M., Marchie, A., Jenkins, A. L., & Axelsen, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76/1.266s · Cited by 379 · cited 2×
“Our analysis also revealed that more than half of the placebo-controlled trials used digestible carbohydrates as a placebo, which have well-documented detrimental effects on immunometabolic markers (29, 30).”
BackgroundKrumbeck, J. A., Rasmussen, H. E., Hutkins, R. W., Clarke, J., Shawron, K., Keshavarzian, A., & Walter, J. (2018) · Microbiome · doi:10.1186/s40168-018-0494-4 · Cited by 342
Self-citationKellow, N. J., Coughlan, M. T., & Reid, C. M. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003607 · Cited by 307 · cited 1×
“These results are in agreement with other systematic reviews that reported reductions in LDL cholesterol (125–132), TC (128, 129, 131, 132), and HOMA-IR (133) from DF supplementation, whereas no effects were observed for CRP and IL-6 (6), fasting glucose and insulin (131), and HDL cholesterol and TG (128, 129, 132, 13…”
ResultCarbohydrate intake and obesity
van Dam, R. M., & Seidell, J. C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602939 · Cited by 261
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level
King, D. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.5.502 · Cited by 241
Jew, S., AbuMweis, S. S., & Jones, P. J. H. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0268 · Cited by 219 · cited 1×
“Most intervention studies in the literature supplement DFs at doses that are insufficient for reliable benefits (20, 159) and are also too low from an evolutionary perspective, given that humans evolved consuming a diet that contained over 100 g/d of DF (22, 143, 160).”
BackgroundKim, Y., & Je, Y. (2016) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2015.09.005 · Cited by 212 · cited 1×
“Although the latter inherently assess the long-term consumption of food matrices comprised of complex mixtures of DFs, having a range of physicochemical properties at doses that reflect a high habitual intake (>20 g/d) (5, 10, 156), intervention studies typically assess the effect of 1 or 2 DF types with a limited ran…”
BackgroundBrighenti, F., Casiraghi, M., Canzi, E., & Ferrari, A. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600841 · Cited by 204 · cited 1×
“Two publications were controlled but not randomized (101, 102); in addition, 20 studies had no control arm.”
BackgroundThompson, S. V., Hannon, B. A., An, R., & Holscher, H. D. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.163246 · Cited by 201 · cited 5×
“Therefore, despite the high proportion of intervention trials with no significant effect, DF might still be an active constituent of whole foods, but its effects might be reduced or lost due to between-study and intersubject heterogeneities (23), and how DF supplements are applied.”
BackgroundResultInfluentialBuyken, A. E., Goletzke, J., Joslowski, G., Felbick, A., Cheng, G., Herder, C., & Brand-Miller, J. C. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.074252 · Cited by 180
Stenman, L. K., Lehtinen, M. J., Meland, N., Christensen, J. E., Yeung, N., Saarinen, M. T., Courtney, M., Burcelin, R., Lähdeaho, M.-L., Linros, J., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.036 · Cited by 177 · cited 1×
“There was only 1 study that supplemented DF for a year, which was a single-arm pilot study (103), and 3 studies that supplemented DF for 6 mo (65, 77, 107).”
BackgroundBrahe, L. K., Le Chatelier, E., Prifti, E., Pons, N., Kennedy, S., Blædel, T., Håkansson, J., Dalsgaard, T. K., Hansen, T., Pedersen, O., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515001786 · Cited by 171
Robertson, M. D., Wright, J. W., Loizon, E., Debard, C., Vidal, H., Shojaee-Moradie, F., Russell-Jones, D., & Umpleby, A. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1513 · Cited by 126
Yang, Y., Zhao, L.-G., Wu, Q.-J., Ma, X., & Xiang, Y.-B. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu257 · Cited by 119 · cited 1×
“Observational studies support the health benefits of high DF intake (5), such as a reduction in low-grade systemic inflammation (6), obesity (7), metabolic syndrome (8, 9), type 2 diabetes (10, 11), and CVD (12, 13), as well as all-cause mortality (14).”
Background
Cited by
Deehan, E. C., Yang, C., Perez-Muñoz, M. E., Nguyen, N. K., Cheng, C. C., Triador, L., Zhang, Z., Bakal, J. A., & Walter, J. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.006 · Cited by 539
Self-citationVan den Abbeele, P., Deyaert, S., Albers, R., Baudot, A., & Mercenier, A. (2023) · Nutrients · doi:10.3390/nu15092090 · Cited by 46
“They are, for instance, recognized as a key contributor for the inconsistent reports on the benefits of fibre intake [15].”
BackgroundDeehan, E. C., Zhang, Z., Nguyen, N. K., Perez-Muñoz, M. E., Cole, J., Riva, A., Berry, D., Prado, C. M., & Walter, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2363021 · Cited by 15
Self-citationShen, H., Chen, D., Wang, S., Jin, Y., & Cheng, W. (2024) · Food & Function · doi:10.1039/d3fo05120j · Cited by 8
Metadata
- Authors
- Armet, A. M., Deehan, E. C., Thöne, J. V., Hewko, S. J., & Walter, J.
- Venue
- Advances in Nutrition
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 11
- Issue
- 2
- Pages
- 420-438
- ISSN
- 2156-5376 (ISSN-L)
- 2161-8313
- OpenAlex
- W2963632228
- Cited by
- 63
- References
- 27
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.